Physician profile
Robert A Herman
NPI 1528171808
$875.42
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $180 · 2021: $36.92 · 2022: $116 · 2024: $38.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $180.02 | 2019-2021 | |
| Allergan, INC. | $143.75 | 2019-2020 | |
| Axonics, INC. | $116.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.73 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.59 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $55.42 | 2019-2024 | |
| Janssen Biotech, INC. | $37.44 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $37.19 | 2019 | |
| Gilead Sciences, INC. | $33.99 | 2019-2020 | |
| Pfizer INC. | $26.23 | 2020 | |
| Dynavax Technologies Corporation | $18.37 | 2019 | |
| Endo Pharmaceuticals INC. | $17.46 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.14 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.29 | 2019 | |
| Merck Sharp & Dohme LLC | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.